Abstract:Objective To investigate the clinical characteristics and associated risk factors for patients with mixed Candida/bacterial bloodstream infections (BSIs).Methods A retrospective study was conducted in the Second Affiliated hHospital of Zhejiang University School of Medicine from February 2012 to June 2015.The clinical data of cases was collected,and the clinical characteristics,the microbiology data and outcomes in patients with mixed Candida/bacterial BSIs confirmed by blood culture were compared with those with candidaemia.A Logistic regression analysis was performed to investigate the independent risk factors.Results A total of 136 candidaemia cases were analyzed including 40 cases (29.4％) of mixed Candida/boacterial BSIs and 96 cases of candidaemia.Among the 136 candidas strains,the proportion of non-albicans exceeded the albicans (50.7％ vs 49.3％),although the later was still the predominant one.There was no significant difference in the distribution of candidas strains between patients with mixed Candida/bacterial BSIs and patients with candidaemia.In patients with mixed Candida/bacterial BSIs,25 strains (61.0％) of gram-positive cocci and 16 strains (39.0％) of gram-negative bacilli were isolated.Compared with patients with candidaemia,patients with mixed Candida/bacterial BSIs needed longer period of antifungal therapy [12.0 (4.0-25.0)days vs 7.0 (3.0-13.5) days,P=0.027],but the crude 30-day and 90-day mortality did not differ between the two groups (40.0％ vs 32.3％;45.0％ vs 36.5％;both P＞0.05).Univariate analysis revealed that the prior hospital stay,ICU admission at the onset of candidaemia,blood transfusion,human albumin infusion,mechanical ventilation,linezolid use and high SOFA score were related with the occurrence of mixed Candida/bacterial BSIs (all P＜0.05).Multivariate analysis showed that only high SOFA score was the independent risk factor (P=0.003).Conclusions Gram-positive cocci were the predominant species in mixed Candida/bacterial BSIs.Compared with candidaemia,mixed Candida/bacterial BSIs needs a longer ICU stay,a longer hospital stay,and a prolonged antifungal therapy.High SOFA score is the independent risk factor for mixed Candida/ bacterial BSIs.

Prognostic value of serial (1,3)-β-d-glucan measurements in ICU patients with invasive candidiasis

Lower (1,3)-beta-d-glucan (BDG) sensitivity and in-vitro levels in Candida auris and Candida parapsilosis strains

Evaluation of colonization index and (1,3)- ß- D glucan as diagnostic tools of invasive candidiasis in a pediatric Intensive Care Unit

Monocyte human leukocyte antigen-DR but not β-d-glucan may help early diagnosing invasive Candida infection in critically ill patients

The Clinical Characteristics and Risk Factors of Mixed Candida/bacterial Bloodstream Infections

Diagnostic performance of the (1-3)-β-d-glucan assay in patients with different risks for invasive fungal diseases

Clinical evaluation of two different (1,3)-ß-d-glucan assays for diagnosis of invasive fungal diseases: A retrospective cohort study

Plasma 1,3-β-d-glucan levels predict adverse clinical outcomes in critical illness

Clinical Features and Prognostic Risk Factors of Candidemia in Non-Intensive Care Unit Wards

Clinical diagnosis value of serum(1,3)-β-D glucan to invasive pulmonary fungal infection

A Diagnostic Stewardship Intervention to Improve Utilization of 1,3 β-D-Glucan Testing at a Single Academic Center: Five-Year Experience

A scoring system based on novel biomarkers and clinical risk factors to predict invasive candidiasis in immunocompetent critically ill patients

Identifying optimal serum 1,3-β-D-Glucan cut-off for diagnosing Pneumocystis Jirovecii Pneumonia in non-HIV patients in the intensive care unit

1701. Differences in Diagnostic Performance of Β-D-glucan Testing in Patients with Varying Degrees of Susceptibility to Invasive Fungal Infections

Evaluation of a Novel Plasma (1,3)-Β- D -Glucan Detection Assay for Diagnosis of Candidemia in Pediatric Patients

The Diagnostic Significance of G/GM Assay for Invasive Fungal Infections in Patients with Hematological Malignancies

Independent risk factors for mortality in critically ill patients with candidemia on Italian Internal Medicine Wards

Detection of Candida DNA in peritoneal fluids by PCR assay optimizing the diagnosis and treatment for intra-abdominal candidiasis in high-risk ICU patients: A prospective cohort study

Invasive Candidiasis in Intensive Care Units in China: a Multicentre Prospective Observational Study

[Value of Plasma Beta-Glucan in Early Diagnosis of Invasive Fungal Infection in Children].

Glucocorticoid use and parenteral nutrition are risk factors for catheter-related Candida bloodstream infection: a retrospective study